IOVANCE BIOTHERAPEUTICS INC's ticker is and the CUSIP is 462260900. A total of 4 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,850,000 | -90.5% | 75,000 | -89.4% | 0.00% | -100.0% |
| Q2 2020 | $19,492,000 | -22.7% | 710,100 | -15.7% | 0.00% | -33.3% |
| Q1 2020 | $25,220,000 | +76.5% | 842,500 | +63.2% | 0.01% | +100.0% |
| Q4 2019 | $14,288,000 | +946.7% | 516,200 | +588.3% | 0.00% | – |
| Q3 2019 | $1,365,000 | – | 75,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 324,500 | $8,908,000 | 0.04% |
| JPMORGAN CHASE & CO | 710,100 | $19,492,000 | 0.00% |
| SIMPLEX TRADING, LLC | 607 | $1,666,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |